Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63(1):181–187

Article  CAS  PubMed  Google Scholar 

Ly A, Lester SC, Dillon D (2012) Prognostic factors for patients with breast cancer: traditional and new. Surg Pathol Clin 5(3):775–785. https://doi.org/10.1016/j.path.2012.06.010

Article  PubMed  Google Scholar 

McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM (1990) How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82(12):1006–1015. https://doi.org/10.1093/jnci/82.12.1006

Article  CAS  PubMed  Google Scholar 

Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL (1990) Cathepsin D and prognosis in breast cancer. N Engl J Med 322(5):297–302. https://doi.org/10.1056/NEJM199002013220504

Article  CAS  PubMed  Google Scholar 

Wong WW, Vijayakumar S, Weichselbaum RR (1992) Prognostic indicators in node-negative early stage breast cancer. Am J Med 92(5):539–548. https://doi.org/10.1016/0002-9343(92)90751-v

Article  CAS  PubMed  Google Scholar 

Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11(1):55–65. https://doi.org/10.1016/S1470-2045(09)70314-6

Article  CAS  PubMed  Google Scholar 

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN (2021) 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med 385(25):2336–2347. https://doi.org/10.1056/NEJMoa2108873

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826. https://doi.org/10.1056/NEJMoa041588

Article  CAS  PubMed  Google Scholar 

Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726–3734. https://doi.org/10.1200/JCO.2005.04.7985

Article  CAS  PubMed  Google Scholar 

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr (2018) Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 379(2):111–121. https://doi.org/10.1056/NEJMoa1804710

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, Zujewski J, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin P, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Atkins JN, Berenberg JL, Sledge GW (2015) Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med 373(21):2005–2014. https://doi.org/10.1056/NEJMoa1510764

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Moreno HLG, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr (2019) Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer. N Engl J Med 380(25):2395–2405. https://doi.org/10.1056/NEJMoa1904819

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hyams DM, Schuur E, Angel Aristizabal J, Bargallo Rocha JE, Cabello C, Elizalde R, Garcia-Estevez L, Gomez HL, Katz A, Nunez De Pierro A (2017) Selecting postoperative adjuvant systemic therapy for early stage breast cancer: a critical assessment of commercially available gene expression assays. J Surg Oncol 115(6):647–662. https://doi.org/10.1002/jso.24561

Article  PubMed  PubMed Central  Google Scholar 

Markopoulos C, Hyams DM, Gomez HL, Harries M, Nakamura S, Traina T, Katz A (2020) Multigene assays in early breast cancer: insights from recent phase 3 studies. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2019.10.019

Article  PubMed  Google Scholar 

Markopoulos C, van de Velde C, Zarca D, Ozmen V, Masetti R (2017) Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information? Eur J Surg Oncol 43(5):909–920. https://doi.org/10.1016/j.ejso.2016.08.012

Article  CAS  PubMed  Google Scholar 

Focke CM, Burger H, van Diest PJ, Finsterbusch K, Glaser D, Korsching E, Decker T, German Breast Screening Pathology Initiative (2017) Interlaboratory variability of Ki67 staining in breast cancer. Eur J Cancer 84:219–227. https://doi.org/10.1016/j.ejca.2017.07.041

Article  CAS  PubMed  Google Scholar 

Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JM, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO, International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (2013) An international ki67 reproducibility study. J Natl Cancer Inst 105(24):1897–1906. https://doi.org/10.1093/jnci/djt306

Article  PubMed  PubMed Central  Google Scholar 

Varga Z, Diebold J, Dommann-Scherrer C, Frick H, Kaup D, Noske A, Obermann E, Ohlschlegel C, Padberg B, Rakozy C, Sancho Oliver S, Schobinger-Clement S, Schreiber-Facklam H, Singer G, Tapia C, Wagner U, Mastropasqua MG, Viale G, Lehr HA (2012) How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the swiss working group of breast-and gynecopathologists. PLoS ONE 7(5):e37379. https://doi.org/10.1371/journal.pone.0037379

Article  CAS  PubMed  PubMed Central  Google Scholar 

NCCN clinical practice guidelines in oncology. Breast Cancer. Version 4.2023. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed, Sep 23, 2023.

Nielsen TO, Leung SCY, Rimm DL, Dodson A, Acs B, Badve S, Denkert C, Ellis MJ, Fineberg S, Flowers M, Kreipe HH, Laenkholm AV, Pan H, Penault-Llorca FM, Polley MY, Salgado R, Smith IE, Sugie T, Bartlett JMS, McShane LM, Dowsett M, Hayes DF (2020) Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group. J Natl Cancer Inst 113(7):808–819. https://doi.org/10.1093/jnci/djaa201

Article  CAS  PubMed Central  Google Scholar 

Nitz U, Gluz O, Christgen M, Kates RE, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Lorenz-Salehi F, Krabisch P, Just M, Augustin D, Liedtke C, Chao C, Shak S, Wuerstlein R, Kreipe HH, Harbeck N (2017) Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: Five-year data from the prospective, randomised phase 3 West German study group (WSG) PlanB trial. Breast Cancer Res Treat 165(3):573–583. https://doi.org/10.1007/s10549-017-4358-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konsti J, Lundin M, Joensuu H, Lehtimaki T, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Sailas L, Isola J, Lundin J (2011) Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer. BMC Clin Pathol 11:3. https://doi.org/10.1186/1472-6890-11-3

Article  PubMed  PubMed Central  Google Scholar 

Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J (2010) ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 12(4):R56. https://doi.org/10.1186/bcr2615

Article  PubMed  PubMed Central  Google Scholar 

Yeo MK, Kim HE, Kim SH, Chae BJ, Song BJ, Lee A (2017) Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer. J Clin Pathol 70(8):715–719. https://doi.org/10.1136/jclinpath-2016-204162

Article  PubMed